We are live on
!
Find out more
AACR
ACR Alpine Capital Research Portfolio holdings
AUM
$6.7B
1-Year Est. Return
33.44%
This Fund
S&P 500
This Quarter
Est. Return
-2.37%
1 Year Est. Return
+33.44%
3 Year Est. Return
+61.38%
5 Year Est. Return
+53.14%
10 Year Est. Return
+201.58%
AUM
$823M
AUM Growth
+$62M
(+8.1%)
Cap. Flow
+$79.3M
Cap. Flow
% of AUM
9.63%
Top 10 Holdings %
Top 10 Hldgs %
88.86%
Holding
22
New
2
Increased
13
Reduced
4
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$44.3M |
| 2 |
JPMorgan Chase
JPM
|
+$16.6M |
| 3 |
Microsoft
MSFT
|
+$15.6M |
| 4 |
Vodafone
VOD
|
+$15.3M |
| 5 |
Johnson & Johnson
JNJ
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$39.3M |
| 2 |
Walmart Inc
WMT
|
+$854K |
| 3 |
Merck
MRK
|
+$132K |
| 4 |
Procter & Gamble
PG
|
+$16.3K |
| 5 |
MetLife
MET
|
+$7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.78% |
| 2 | Technology | 19.39% |
| 3 | Financials | 15.09% |
| 4 | Consumer Staples | 14.59% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
JPMorgan Chase
JPM
$939B
| $86.3M | 10.48% |
1,423,868
+279,622
| +24% | +$16.6M |
|
|
2
Microsoft
MSFT
$2.84T
| $84.9M | 10.31% |
2,087,924
+357,624
| +21% | +$15.6M |
|
|
3
Johnson & Johnson
JNJ
$635B
| $84.6M | 10.28% |
840,753
+118,685
| +16% | +$12.1M |
|
|
4
Vodafone
VOD
$34.9B
| $79.4M | 9.65% |
2,429,944
+446,095
| +22% | +$15.3M |
|
|
5
Intel
INTC
$466B
| $74.7M | 9.07% |
2,388,429
+1,311,858
| +122% | +$44.3M |
|
|
6
Humana
HUM
$46.7B
| $68.3M | 8.3% |
383,629
-248,256
| -39% | -$39.3M |
|
7
Sysco
SYY
$39.7B
| $68.2M | 8.28% |
1,806,389
+84,760
| +5% | +$3.34M |
|
|
ESRX
8
DELISTED
Express Scripts Holding Company
ESRX
| $67.2M | 8.16% |
773,936
+49,300
| +7% | +$4.13M |
|
|
9
Merck
MRK
$324B
| $66.2M | 8.05% |
1,207,247
-2,338
| -0.2% | -$132K |
|
|
10
Walmart Inc
WMT
$871B
| $51.7M | 6.28% |
1,886,079
-30,120
| -2% | -$854K |
|
|
RFP
11
DELISTED
Resolute Forest Products Inc.
RFP
| $49.8M | 6.05% |
2,887,705
+397,348
| +16% | +$6.84M |
|
12
Berkshire Hathaway Class B
BRK.B
$1.07T
| $37.2M | 4.52% |
257,554
+355
| +0.1% | +$52.2K |
|
13
Vanguard Total Stock Market ETF
VTI
$654B
| $1.1M | 0.13% |
10,302
+454
| +5% | +$48.5K |
|
14
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $1.08M | 0.13% |
13,421
+2,469
| +23% | +$198K |
|
15
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $614K | 0.07% |
+23,224
| New | +$612K |
|
16
Southern Missouri Bancorp
SMBC
$855M
| $413K | 0.05% |
21,900
+2,662
| +14% | +$50.1K |
|
17
Liberty Global Class C
LBTYK
$3.27B
| $376K | 0.05% |
+9,333
| New | +$370K |
|
18
Kingstone Companies
KINS
$288M
| $334K | 0.04% |
44,361
+16,919
| +62% | +$132K |
|
|
19
Procter & Gamble
PG
$343B
| $256K | 0.03% |
3,119
-189
| -6% | -$16.3K |
|
|
JPM.WS
20
DELISTED
JPMorgan Chase
JPM.WS
| $88K | 0.01% |
4,000
| – | – |
|
|
21
MetLife
MET
$61B
| – | – |
-154
| Closed | -$7K |
|
Similar funds
MSE
MIP
FLPIM
BHM
SPS
SPC
TAM
TB
ACR Alpine Capital Research's Q1 2015 Portfolio in Review
As of Q1 2015, ACR Alpine Capital Research held 22 positions worth $823M, up 8.1% from $761M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
ACR Alpine Capital Research deployed $79.3M of net new capital in Q1 2015, opening 2 new positions and adding to 13 existing holdings. Its largest new stake was Schwab US Aggregate Bond ETF: 23,224 shares worth $614K.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Humana, an estimated $39.3M trimmed.
- ACR Alpine Capital Research's largest Q1 2015 buy was Schwab US Aggregate Bond ETF: 23,224 shares worth $614K.
- ACR Alpine Capital Research added most to Intel in Q1 2015, an estimated $44.3M increase.
- ACR Alpine Capital Research's biggest Q1 2015 reduction was Humana, cutting an estimated $39.3M.
- ACR Alpine Capital Research fully exited MetLife in Q1 2015, selling an estimated $7K.
- ACR Alpine Capital Research's ten largest holdings make up 89% of its $823M portfolio in Q1 2015.
- ACR Alpine Capital Research opened 2 new positions and closed 1 in Q1 2015.
- ACR Alpine Capital Research's portfolio value rose 8.1% quarter-over-quarter to $823M.
Based on ACR Alpine Capital Research's 13F filing for Q1 2015, filed 13 May 2015.